
Pfizer is testing a pill to ward off COVID-19
CBSN
Pfizer said Monday that it is now testing a pill that could help people ward off COVID-19 if a close contact, such as family member, gets the virus.
The drugmaker said it is looking at the efficacy of the pill as used in combination with a low dose of the HIV drug ritonavir in people who are at least 18 years old and live in the same household with someone who has COVID-19.
Pfizer plans to enroll 2,660 people in the late-stage study. Those participating will get either the treatment combination or a fake drug orally twice a day for five to 10 days.

A week before an expected committee vote on the controversial nomination of Trump ally Emil Bove for a federal judgeship, CBS News has obtained emails and text messages shared with Congress by a whistleblower who accuses Bove of unethical actions while he was a top Justice Department official this year.

French university courts American researchers seeking "scientific asylum" amid Trump's academic cuts
A university in France says nearly 300 American researchers have applied for a space in its "Safe Place for Science" program that was created to lure U.S. researchers seeking "scientific asylum" amid aggressive academic spending cuts and other actions against colleges by the Trump administration.